Gress T - Search Results

1

Screening technologies for target identification in pancreatic cancer.

Michl P, Ripka S, Gress T, Buchholz M. Michl P, et al. Among authors: gress t. Cancers (Basel). 2010 Dec 29;3(1):79-90. doi: 10.3390/cancers3010079. Cancers (Basel). 2010. PMID: 24212607 Free PMC article.

2

aRNA-longSAGE: a new approach to generate SAGE libraries from microdissected cells.

Heidenblut AM, Lüttges J, Buchholz M, Heinitz C, Emmersen J, Nielsen KL, Schreiter P, Souquet M, Nowacki S, Herbrand U, Klöppel G, Schmiegel W, Gress T, Hahn SA. Heidenblut AM, et al. Among authors: gress t. Nucleic Acids Res. 2004 Sep 15;32(16):e131. doi: 10.1093/nar/gnh130. Nucleic Acids Res. 2004. PMID: 15371555 Free PMC article.

3

CUTL1 is a target of TGF(beta) signaling that enhances cancer cell motility and invasiveness.

Michl P, Ramjaun AR, Pardo OE, Warne PH, Wagner M, Poulsom R, D'Arrigo C, Ryder K, Menke A, Gress T, Downward J. Michl P, et al. Among authors: gress t. Cancer Cell. 2005 Jun;7(6):521-32. doi: 10.1016/j.ccr.2005.05.018. Cancer Cell. 2005. PMID: 15950902 Free article.

4

The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.

Buck A, Buchholz M, Wagner M, Adler G, Gress T, Ellenrieder V. Buck A, et al. Among authors: gress t. Mol Cancer Res. 2006 Nov;4(11):861-72. doi: 10.1158/1541-7786.MCR-06-0081. Mol Cancer Res. 2006. PMID: 17114344

5

Medical treatment of gastroenteropancreatic neuroendocrine tumors.

Rinke A, Michl P, Gress T. Rinke A, et al. Among authors: gress t. Cancers (Basel). 2012 Feb 8;4(1):113-29. doi: 10.3390/cancers4010113. Cancers (Basel). 2012. PMID: 24213230 Free PMC article.

6

Synthetic lethality screen identifies RPS6KA2 as modifier of epidermal growth factor receptor activity in pancreatic cancer.

Milosevic N, Kühnemuth B, Mühlberg L, Ripka S, Griesmann H, Lölkes C, Buchholz M, Aust D, Pilarsky C, Krug S, Gress T, Michl P. Milosevic N, et al. Among authors: gress t. Neoplasia. 2013 Dec;15(12):1354-62. doi: 10.1593/neo.131660. Neoplasia. 2013. PMID: 24403857 Free PMC article.

7

Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.

Hermann PC, Sancho P, Cañamero M, Martinelli P, Madriles F, Michl P, Gress T, de Pascual R, Gandia L, Guerra C, Barbacid M, Wagner M, Vieira CR, Aicher A, Real FX, Sainz B Jr, Heeschen C. Hermann PC, et al. Among authors: gress t. Gastroenterology. 2014 Nov;147(5):1119-33.e4. doi: 10.1053/j.gastro.2014.08.002. Epub 2014 Aug 12. Gastroenterology. 2014. PMID: 25127677

8

Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation.

Behm B, Di Fazio P, Michl P, Neureiter D, Kemmerling R, Hahn EG, Strobel D, Gress T, Schuppan D, Wissniowski TT. Behm B, et al. Among authors: gress t. Gut. 2016 Jan;65(1):134-43. doi: 10.1136/gutjnl-2014-308286. Epub 2014 Dec 18. Gut. 2016. PMID: 25524262

9

Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.

Stangel D, Erkan M, Buchholz M, Gress T, Michalski C, Raulefs S, Friess H, Kleeff J. Stangel D, et al. Among authors: gress t. J Surg Res. 2015 Jul;197(1):91-100. doi: 10.1016/j.jss.2015.03.070. Epub 2015 Mar 30. J Surg Res. 2015. PMID: 25953216

10

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment Stratification.

Krug S, Boch M, Daniel H, Nimphius W, Müller D, Michl P, Rinke A, Gress TM. Krug S, et al. PLoS One. 2015 Dec 2;10(12):e0143822. doi: 10.1371/journal.pone.0143822. eCollection 2015. PLoS One. 2015. PMID: 26630134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

360 results

Search Page